A tech start-up which developed a wearable monitoring device to help hospitals pick up warning signs of deteriorating health in patients more quickly has secured £2m in funding.
Snap40 plans to expand its engineering and data science team, complete clinical trials and gain regulatory clearance, opening up the EU market.
The Edinburgh-based firm also aims to move into the US market next year.
The funding round was led by Edinburgh-based investment firm Par Equity.
It is thought to be one of the largest seed rounds achieved by a Scotland-based start-up.
The company is led by chief executive and co-founder Christopher McCann, a former medical student at the University of Dundee.
Get more on this story on the BBC website
Come join us